Literature DB >> 22729254

[Guidelines for budget impact analysis of health technologies in Brazil].

Andre Luis Ferreira-Da-Silva1, Rodrigo Antonini Ribeiro, Vânia Cristina Canuto Santos, Flávia Tavares Silva Elias, Alexandre Lemgruber Portugal d'Oliveira, Carisi Anne Polanczyk.   

Abstract

Budget impact analysis (BIA) provides operational financial forecasts to implement new technologies in healthcare systems. There were no previous specific recommendations to conduct such analyses in Brazil. This paper reviews BIA methods for health technologies and proposes BIA guidelines for the public and private Brazilian healthcare system. The following recommendations were made: adopt the budget administrator's perspective; use a timeframe of 1 to 5 years; compare reference and alternative scenarios; consider the technology's rate of incorporation; estimate the target population by either an epidemiological approach or measured demand; consider restrictions on technologies' indication or factors that increase the demand for them; consider direct and averted costs; do not adjust for inflation or discounts; preferably, integrate information on a spreadsheet; calculate the incremental budget impact between scenarios; and summarize information in a budget impact report.

Mesh:

Year:  2012        PMID: 22729254     DOI: 10.1590/s0102-311x2012000700002

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  13 in total

Review 1.  A Methodological Review of US Budget-Impact Models for New Drugs.

Authors:  Josephine Mauskopf; Stephanie Earnshaw
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

2.  Budget impact of applying appropriateness criteria for myocardial perfusion scintigraphy: The perspective of a developing country.

Authors:  Mauro Augusto Dos Santos; Marisa Silva Santos; Bernardo Rangel Tura; Renata Félix; Adriana Soares X Brito; Andrea De Lorenzo
Journal:  J Nucl Cardiol       Date:  2016-05-26       Impact factor: 5.952

3.  The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil.

Authors:  Wânia Cristina da Silva; Brian Godman; Francisco de Assis Acúrcio; Mariângela Leal Cherchiglia; Antony Martin; Konrad Maruszczyk; Jans Bastos Izidoro; Marcos André Portella; Agner Pereira Lana; Orozimbo Henriques Campos Neto; Eli Iola Gurgel Andrade
Journal:  Appl Health Econ Health Policy       Date:  2021-01-28       Impact factor: 2.561

4.  Budget impact from the incorporation of positron emission tomography - computed tomography for staging lung cancers.

Authors:  Aline Navega Biz; Rosângela Caetano
Journal:  Rev Saude Publica       Date:  2015-08-11       Impact factor: 2.106

Review 5.  G6PD deficiency in Latin America: systematic review on prevalence and variants.

Authors:  Wuelton M Monteiro; Fernando F A Val; André M Siqueira; Gabriel P Franca; Vanderson S Sampaio; Gisely C Melo; Anne C G Almeida; Marcelo A M Brito; Henry M Peixoto; Douglas Fuller; Quique Bassat; Gustavo A S Romero; Oliveira Maria Regina F; Lacerda Marcus Vinícius G
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-19       Impact factor: 2.743

6.  Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H in TP53.

Authors:  Mariana Fitarelli-Kiehl; Gabriel S Macedo; Rosane Paixão Schlatter; Patricia Koehler-Santos; Ursula da Silveira Matte; Patricia Ashton-Prolla; Juliana Giacomazzi
Journal:  Genet Mol Biol       Date:  2016-06-03       Impact factor: 1.771

7.  Budget Impact of Long-Acting Insulin Analogues: The Case in Brazil.

Authors:  Fernanda O Laranjeira; Everton Nunes da Silva; Maurício G Pereira
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 8.  A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions.

Authors:  Naghmeh Foroutan; Jean-Eric Tarride; Feng Xie; Mitchell Levine
Journal:  Clinicoecon Outcomes Res       Date:  2018-11-26

9.  National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India.

Authors:  Shankar Prinja; Yashika Chugh; Kavitha Rajsekar; V R Muraleedharan
Journal:  Appl Health Econ Health Policy       Date:  2021-06-29       Impact factor: 2.561

10.  Treatment Options for Age-Related Macular Degeneration: A Budget Impact Analysis from the Perspective of the Brazilian Public Health System.

Authors:  Flávia Tavares Silva Elias; Everton Nunes da Silva; Rubens Belfort; Marcus Tolentino Silva; Álvaro Nagib Atallah
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.